Overview

Benefits of ADHD Treatment in Detained People

Status:
Not yet recruiting
Trial end date:
2026-10-30
Target enrollment:
Participant gender:
Summary
Attention deficit hyperactivity disorder (ADHD) is characterized by difficulties paying attention, poor impulse control, and hyperactive behaviors. It is associated with several health and social detrimental outcomes and leads to increased risks of criminality and recidivism. However, to date, ADHD treatment has been neglected in prison. This project will test the efficacy of ADHD treatment using a randomized controlled trial.
Phase:
Phase 3
Details
Lead Sponsor:
Stéphanie Baggio
Collaborators:
Netherlands Institute for the Study of Crime
School of Health Sciences Fribourg
University of Geneva, Switzerland
University of Lausanne
Treatments:
Methylphenidate